Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome

Archives of Pediatrics and Adolescent Medicine

Volumn 165, Issue 10, 2011, Pages 884-889

  Hickey, Christina A ^a   Beattie, T James ^b   Cowieson, Jennifer ^b   Miyashita, Yosuke ^c   Strife, C Frederic ^d   Frem, Juliana C ^e   Peterson, Johann M ^f   Butani, Lavjay ^f   Jones, Deborah P ^g   Havens, Peter L ^h   Patel, Hiren P ⁱ   Wong, Craig S ^j   Andreoli, Sharon P ^k   Rothbaum, Robert J ^a   Beck, Anne M ^a   Tarr, Phillip I ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h Medical College of Wisconsin Children's Hospital of Wisconsin ^*  (United States)

ⁱ THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF NEW MEXICO   (United States)

^k INDIANA UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INFUSION FLUID; SODIUM;

ADOLESCENT; ANURIA; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE ASSOCIATION; FEMALE; HEMATOCRIT; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTRAVENOUS ADMINISTRATION; KIDNEY DYSFUNCTION; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OLIGURIA; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL PROTECTION; RISK FACTOR; SCHOOL CHILD; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNITED STATES; URINE VOLUME;

ACUTE KIDNEY INJURY; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIARRHEA; FEMALE; FLUID THERAPY; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; OLIGURIA; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80053405654     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2011.152     Document Type: Article

References (29)

1. Ake JA, Jelacic S, Ciol MA, et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics. 2005;115(6):e673-e680. (Pubitemid 43852790)
2. Oakes RS, Kirkham JK, Nelson RD, Siegler RL. Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome [correction appears in Pediatr Nephrol. 2008;23(11):2105]. Pediatr Nephrol. 2008;23(8):1303-1308.
3. Loirat C. Post-diarrhea hemolytic-uremic syndrome: clinical aspects. Arch Pediatr. 2001;8(suppl 4):776s-784s.
4. Siegler RL, Pavia AT, Christofferson RD, Milligan MK. A 20-year populationbased study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics. 1994; 94(1):35-40. (Pubitemid 24194093)
5. Siegler RL, Milligan MK, Burningham TH, Christofferson RD, Chang SY, Jorde LB. Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome. J Pediatr. 1991;118(2):195-200.
6. Garg AX, Suri RS, Barrowman N, et al. Long-term renal prognosis of diarrheaassociated hemolytic uremic syndrome: a systematic review,meta-analysis, and meta-regression. JAMA. 2003;290(10):1360-1370. (Pubitemid 37442634)
7. Robson WL, Leung AK, Brant R. Relationship of the recovery in the glomerular filtration rate to the duration of anuria in diarrhea-associated hemolytic uremic syndrome. Am J Nephrol. 1993;13(3):194-197. (Pubitemid 23242744)
8. Tönshoff B, Sammet A, Sanden I, Mehls O, Waldherr R, Schärer K. Outcome and prognostic determinants in the hemolytic uremic syndrome of children. Nephron. 1994;68(1):63-70. (Pubitemid 24251190)
9. Hüseman D, Gellermann J, Vollmer I, et al. Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow. Pediatr Nephrol. 1999;13 (8):672-677. (Pubitemid 29438448)
10. Mizusawa Y, Pitcher LA, Burke JR, Falk MC, Mizushima W. Survey of haemolyticuraemic syndrome in Queensland 1979-1995. Med J Aust. 1996;165(4):188-191. (Pubitemid 26302433)
11. Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR. Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol. 1997;11(2):156-160. (Pubitemid 27122682)
12. Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo G. The hemolytic-uremic syndrome: renal status of 76 patients at long-term follow-up. J Pediatr. 1968; 72(6):757-765.
13. Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET. The hemolyticuremic syndrome. Nephron. 1973;11(2):174-192.
14. Dolislager D, Tune B. The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome. Am J Dis Child. 1978;132(1):55-58.
15. De Jong MC, Monnens LA. Recurrent haemolytic uraemic syndrome. Padiatr Padol. 1976;11(3):521-527.
16. Mencía Bartolomé S, Martínez de Azagra A, De Vicente Aymat A, Monleón Luque M, Casado Flores J. Uremic hemolytic syndrome: analysis of 43 cases. An Esp Pediatr. 1999;50(5):467-470. (Pubitemid 29283836)
17. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365(9464):1073-1086. (Pubitemid 40386785)
18. Chandler WL, Jelacic S, Boster DR, et al. Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med. 2002;346(1):23-32. (Pubitemid 34438916)
19. Tsai HM, Chandler WL, Sarode R, et al. von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7- associated hemolytic uremic syndrome. Pediatr Res. 2001;49(5):653-659. (Pubitemid 32390854)
20. Holtz LR, Neill MA, Tarr PI. Acute bloody diarrhea: a medical emergency for patients of all ages. Gastroenterology. 2009;136(6):1887-1898.
21. Ostroff SM, Kobayashi JM, Lewis JH. Infections with Escherichia coli O157:H7 in Washington State: the first year of statewide disease surveillance. JAMA. 1989; 262(3):355-359. (Pubitemid 19182839)
22. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolyticuremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342(26):1930-1936. (Pubitemid 30419087)
23. Klein EJ, Stapp JR, Clausen CR, et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr. 2002;141 (2):172-177.
24. Ahn CK, Holt NJ, Tarr PI. Shiga-toxin producing Escherichia coli and the hemolytic uremic syndrome: what have we learned in the past 25 years? Adv Exp Med Biol. 2009;634:1-17.
25. Hsu CW, Symons JM. Acute kidney injury: can we improve prognosis? Pediatr Nephrol. 2010;25(12):2401-2412.
26. Banatvala N, Griffin PM, Greene KD, et al Hemolytic Uremic Syndrome Study Collaborators. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis. 2001;183(7):1063-1070. (Pubitemid 32230954)
27. Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis. 1990;162(2):553-556. (Pubitemid 20239981)
28. Gould LH, Bopp C, Strockbine N, et al Centers for Disease Control and Prevention (CDC). Recommendations for diagnosis of shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep. 2009;58 (RR-12):1-14.
29. Werber D, Mason BW, Evans MR, Salmon RL. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin Infect Dis. 2008;46(8):1189-1196. (Pubitemid 351589901)